Location: Immunity and Disease Prevention ResearchTitle: Provitamin A carotenoids and immune function Author
Submitted to: Book Chapter
Publication Type: Book / Chapter
Publication Acceptance Date: 12/2/2011
Publication Date: 1/1/2013
Citation: Stephensen, C.B. 2013. Provitamin A carotenoids and immune function. In: Tanumihardjo, S. Carotenoids and Human Health. New York, NY: Humana Press. pp. 261-270. Interpretive Summary: Vitamin A has long been referred to as "the anti-infective vitamin" because of its role in maintaining immune function in humans and other animals. This chapter discusses the specific defects caused by vitamin A deficiency and how vitamin A promotes these defenses at the molecular level. In particular, vitamin A deficiency disrupts the ability of epithelial cell barriers to resist bacterial infection in the respirator and intestinal tracts. In addition, cells of the immune system (e.g., lymphocytes, granulocytes, macrophages) require vitamin A for optimal functioning to resist bacteria, viruses and parasites that cross the epithelial barrier. In addition to decreasing resistance to infection, vitamin A deficiency can also impair the serum antibody response to many vaccines. While most studies examining such mechanisms have been done in experimental animals these same mechanisms are presumed to operate in humans.
Technical Abstract: Vitamin A was called the anti-infective vitamin early in the 20th century when vitamin A deficiency was shown to increase the severity of infections of experimental animals. Squamous metaplasia caused by vitamin A deficiency was known to disrupt the mucosal barrier to infection at that time but later insights into how vitamin A deficiency impaired vitamin A deficiency awaited the development of research methods in cellular immunology, and identification of retinoic acid as the key vitamin A metabolite active in the immune system, late in the 20th century. It is now evident from studies in rodents that vitamin A deficiency impairs many aspects of both innate and adaptive immunity, but particularly development of antibody responses to T cell-dependent antigens, secretory IgA responses at mucosal surfaces, development of T-helper cell subsets, and trafficking of lymphocytes to the intestinal tract. These defects are also presumed to occur in humans though data are quite limited. Correcting such defects is presumably responsible for the ability of vitamin A supplementation to decrease the risk of mortality from some common infections of childhood (e.g., diarrhea and measles) in infants over six months of age in developing country settings where the risk of death from such infections is high.